Skip to main content
Earnings Labs
Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ·Healthcare·Biotechnology

$47.60

+0.68%

Mkt Cap $874.78M

Analyst Ratings

Buy

6

Hold

1

Sell

0

Price Target (4 analysts)

$27.33

Range $2.00$42.00

Implied Upside

-42.6%

Consensus $27.33 vs current $47.60